{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:19:01Z","timestamp":1786979941707,"version":"build-2736575974"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2019,3,19]],"date-time":"2019-03-19T00:00:00Z","timestamp":1552953600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Chemother Pharmacol"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1007\/s00280-019-03816-3","type":"journal-article","created":{"date-parts":[[2019,3,19]],"date-time":"2019-03-19T03:04:48Z","timestamp":1552964688000},"page":"1017-1024","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["d,l-Methadone does not improve radio- and chemotherapy in glioblastoma in vitro"],"prefix":"10.1007","volume":"83","author":[{"given":"Henry","family":"Oppermann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Matusova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annegret","family":"Glasow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Dietterle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rainer","family":"Baran-Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karsten","family":"Neumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Meixensberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6628-0605","authenticated-orcid":false,"given":"Frank","family":"Gaunitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,3,19]]},"reference":[{"issue":"suppl_5","key":"3816_CR1","doi-asserted-by":"publisher","first-page":"v1","DOI":"10.1093\/neuonc\/now207","volume":"18","author":"QT Ostrom","year":"2016","unstructured":"Ostrom QT, Gittleman H, Xu J et al (2016) CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2009\u20132013. Neuro-Oncology 18(suppl_5):v1\u2013v75. https:\/\/doi.org\/10.1093\/neuonc\/now207","journal-title":"Neuro-Oncology"},{"issue":"10","key":"3816_CR2","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa043330","volume":"352","author":"R Stupp","year":"2005","unstructured":"Stupp R, Mason WP, van den Bent MJ et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352(10):987\u2013996","journal-title":"N Engl J Med"},{"issue":"23","key":"3816_CR3","doi-asserted-by":"publisher","first-page":"2306","DOI":"10.1001\/jama.2017.18718","volume":"318","author":"R Stupp","year":"2017","unstructured":"Stupp R, Taillibert S, Kanner A et al (2017) Effect of tumor-treating fields plus maintenance temozolomide vs maintenance temozolomide alone on survival in patients with glioblastoma: a randomized clinical trial. JAMA 318(23):2306\u20132316. https:\/\/doi.org\/10.1001\/jama.2017.18718","journal-title":"JAMA"},{"issue":"33\u201334","key":"3816_CR4","first-page":"A","volume":"114","author":"J H\u00fcbner","year":"2017","unstructured":"H\u00fcbner J, Hartmann M, Wedding U et al (2017) Methadon in der Onkologie: \u201cStrohhalmfunktion\u201d ohne Evidenz. Dtsch Arztebl International 114(33\u201334):A\u2013A1530","journal-title":"Dtsch Arztebl International"},{"issue":"4","key":"3816_CR5","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s00481-017-0460-x","volume":"29","author":"E Winkler","year":"2017","unstructured":"Winkler E (2017) Methadon gegen Krebs\u2014auch eine Frage f\u00fcr die Ethik und Theorie der Medizin. Ethik Med 29(4):269\u2013272. https:\/\/doi.org\/10.1007\/s00481-017-0460-x","journal-title":"Ethik Med"},{"issue":"10","key":"3816_CR6","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.4161\/cc.28493","volume":"13","author":"C Friesen","year":"2014","unstructured":"Friesen C, Hormann I, Roscher M et al (2014) Opioid receptor activation triggering downregulation of cAMP improves effectiveness of anti-cancer drugs in treatment of glioblastoma. Cell Cycle 13(10):1560\u20131570. https:\/\/doi.org\/10.4161\/cc.28493","journal-title":"Cell Cycle"},{"issue":"3","key":"3816_CR7","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.21873\/anticanres.11438","volume":"37","author":"J Onken","year":"2017","unstructured":"Onken J, Friesen C, Vajkoczy P et al (2017) Safety and tolerance of d,l-methadone in combination with chemotherapy in patients with glioma. Anticancer Res 37(3):1227\u20131235. https:\/\/doi.org\/10.21873\/anticanres.11438","journal-title":"Anticancer Res"},{"key":"3816_CR8","doi-asserted-by":"publisher","DOI":"10.2217\/cns-2018-0006","author":"K Brawanski","year":"2018","unstructured":"Brawanski K, Brockhoff G, Hau P et al (2018) Efficacy of d,l-methadone in the treatment of glioblastoma in vitro. CNS Oncol. https:\/\/doi.org\/10.2217\/cns-2018-0006","journal-title":"CNS Oncol"},{"key":"3816_CR9","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s12935-018-0611-2","volume":"18","author":"H Oppermann","year":"2018","unstructured":"Oppermann H, Dietterle J, Purcz K et al (2018) Carnosine selectively inhibits migration of IDH-wildtype glioblastoma cells in a co-culture model with fibroblasts. Cancer Cell Int 18:111. https:\/\/doi.org\/10.1186\/s12935-018-0611-2","journal-title":"Cancer Cell Int"},{"issue":"3","key":"3816_CR10","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1007\/s10014-012-0081-5","volume":"29","author":"H Arai","year":"2012","unstructured":"Arai H, Ikota H, Sugawara K-i et al (2012) Nestin expression in brain tumors: its utility for pathological diagnosis and correlation with the prognosis of high-grade gliomas. Brain Tumor Pathol 29(3):160\u2013167. https:\/\/doi.org\/10.1007\/s10014-012-0081-5","journal-title":"Brain Tumor Pathol"},{"issue":"2","key":"3816_CR11","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1177\/030089168607200208","volume":"72","author":"D Schiffer","year":"1986","unstructured":"Schiffer D, Giordana MT, Germano I et al (1986) Anaplasia and heterogeneity of GFAP expression in gliomas. Tumori 72(2):163\u2013170","journal-title":"Tumori"},{"issue":"7","key":"3816_CR12","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nmeth.2089","volume":"9","author":"CA Schneider","year":"2012","unstructured":"Schneider CA, Rasband WS, Eliceiri KW (2012) NIH image to ImageJ: 25 years of image analysis. Nat Methods 9(7):671\u2013675","journal-title":"Nat Methods"},{"issue":"6","key":"3816_CR13","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1093\/neuonc\/not003","volume":"15","author":"F Merz","year":"2013","unstructured":"Merz F, Gaunitz F, Dehghani F et al (2013) Organotypic slice cultures of human glioblastoma reveal different susceptibilities to treatments. Neuro-Oncology 15(6):670\u2013681. https:\/\/doi.org\/10.1093\/neuonc\/not003","journal-title":"Neuro-Oncology"},{"key":"3816_CR14","doi-asserted-by":"publisher","DOI":"10.1007\/s00726-018-2619-2","author":"H Oppermann","year":"2018","unstructured":"Oppermann H, Alvanos A, Seidel C et al (2018) Carnosine influences transcription via epigenetic regulation as demonstrated by enhanced histone acetylation of the pyruvate dehydrogenase kinase 4 promoter in glioblastoma cells. Amino Acids. https:\/\/doi.org\/10.1007\/s00726-018-2619-2","journal-title":"Amino Acids"},{"issue":"1","key":"3816_CR15","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B (Methodol) 57(1):289\u2013300","journal-title":"J R Stat Soc Ser B (Methodol)"},{"issue":"1\u20132","key":"3816_CR16","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.molbrainres.2003.11.009","volume":"121","author":"M Ferrer-Alc\u00f3n","year":"2004","unstructured":"Ferrer-Alc\u00f3n M, La Harpe R, Garc\u00eda-Sevilla JA (2004) Decreased immunodensities of micro-opioid receptors, receptor kinases GRK 2\/6 and beta-arrestin-2 in postmortem brains of opiate addicts. Brain Res Mol Brain Res 121(1\u20132):114\u2013122. https:\/\/doi.org\/10.1016\/j.molbrainres.2003.11.009","journal-title":"Brain Res Mol Brain Res"},{"key":"3816_CR17","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.lfs.2016.02.078","volume":"150","author":"K Saify","year":"2016","unstructured":"Saify K, Saadat M (2016) Expression levels of OPRM1 and PDYN in human SH-SY5Y cells treated with morphine and methadone. Life Sci 150:39\u201341. https:\/\/doi.org\/10.1016\/j.lfs.2016.02.078","journal-title":"Life Sci"},{"issue":"14","key":"3816_CR18","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.2165\/00003088-200241140-00003","volume":"41","author":"CB Eap","year":"2002","unstructured":"Eap CB, Buclin T, Baumann P (2002) Interindividual variability of the clinical pharmacokinetics of methadone: implications for the treatment of opioid dependence. Clin Pharmacokinet 41(14):1153\u20131193. https:\/\/doi.org\/10.2165\/00003088-200241140-00003","journal-title":"Clin Pharmacokinet"},{"issue":"4","key":"3816_CR19","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1080\/J354v19n04_05","volume":"19","author":"RA Lugo","year":"2005","unstructured":"Lugo RA, Satterfield KL, Kern SE (2005) Pharmacokinetics of methadone. J Pain Palliat Care Pharmacother 19(4):13\u201324. https:\/\/doi.org\/10.1080\/J354v19n04_05","journal-title":"J Pain Palliat Care Pharmacother"},{"issue":"4","key":"3816_CR20","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1136\/jcp.53.4.277","volume":"53","author":"CM Milroy","year":"2000","unstructured":"Milroy CM (2000) Methadone deaths: a toxicological analysis. J Clin Pathol 53(4):277\u2013281. https:\/\/doi.org\/10.1136\/jcp.53.4.277","journal-title":"J Clin Pathol"},{"issue":"7\u20138","key":"3816_CR21","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s10354-018-0623-5","volume":"168","author":"G Kreye","year":"2018","unstructured":"Kreye G, Masel E-K, Hackner K et al (2018) Methadon als antitumortherapie: Schwindel, Hoffnung oder Risiko?: Eine Serie von Kasuistiken und kurzer \u00dcberblick \u00fcber aktuelle Literatur sowie Empfehlungen der Fachgesellschaften (Methadone as anticancer treatment: hype, hope, or hazard?: a series of case reports and a short review of the current literature and recommendations of the societies). Wien Med Wochenschr 168(7\u20138):159\u2013167. https:\/\/doi.org\/10.1007\/s10354-018-0623-5","journal-title":"Wien Med Wochenschr"},{"issue":"2","key":"3816_CR22","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1111\/j.2042-7158.2012.01567.x","volume":"65","author":"O Tacar","year":"2013","unstructured":"Tacar O, Sriamornsak P, Dass CR (2013) Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems. J Pharm Pharmacol 65(2):157\u2013170. https:\/\/doi.org\/10.1111\/j.2042-7158.2012.01567.x","journal-title":"J Pharm Pharmacol"},{"issue":"3","key":"3816_CR23","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.21873\/anticanres.12360","volume":"38","author":"M Michalska","year":"2018","unstructured":"Michalska M, Schultze-Seemann S, Kuckuck I et al (2018) Impact of methadone on cisplatin treatment of bladder cancer cells. Anticancer Res 38(3):1369\u20131375. https:\/\/doi.org\/10.21873\/anticanres.12360","journal-title":"Anticancer Res"},{"issue":"6","key":"3816_CR24","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1111\/exd.13543","volume":"27","author":"M-C Br\u00fcggen","year":"2018","unstructured":"Br\u00fcggen M-C, Mangana J, Irmisch A et al (2018) Methadone-Not a magic bullet in melanoma therapy. Exp Dermatol 27(6):694\u2013696. https:\/\/doi.org\/10.1111\/exd.13543","journal-title":"Exp Dermatol"},{"issue":"4","key":"3816_CR25","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1073\/pnas.89.4.1169","volume":"89","author":"R Maneckjee","year":"1992","unstructured":"Maneckjee R, Minna JD (1992) Nonconventional opioid binding sites mediate growth inhibitory effects of methadone on human lung cancer cells. Proc Natl Acad Sci USA 89(4):1169\u20131173","journal-title":"Proc Natl Acad Sci USA"},{"key":"3816_CR26","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s10989-007-9121-0","volume":"14","author":"C Renner","year":"2008","unstructured":"Renner C, Seyffarth A, Arriba S de et al (2008) Carnosine inhibits growth of cells isolated from human glioblastoma multiforme. Int J Pept Res Ther 14:127\u2013135. https:\/\/doi.org\/10.1007\/s10989-007-9121-0","journal-title":"Int J Pept Res Ther"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-019-03816-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00280-019-03816-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-019-03816-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T18:22:07Z","timestamp":1721067727000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00280-019-03816-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,19]]},"references-count":26,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["3816"],"URL":"https:\/\/doi.org\/10.1007\/s00280-019-03816-3","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"value":"0344-5704","type":"print"},{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,19]]},"assertion":[{"value":"19 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors report no conflicts of interest in this work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All patients provided written informed consent according to German law as confirmed by the local committee (#144-2008) in accordance with the 1964 Helsinki declaration and its later amendments.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informant consent"}}]}}